RXST
Price:
$52.95
Market Cap:
$2.10B
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. ...[Read more]
Industry
Medical - Devices
IPO Date
2021-07-30
Stock Exchange
NASDAQ
Ticker
RXST
According to RxSight, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -54.03. This represents a change of 7.82% compared to the average of -50.11 of the last 4 quarters.
The mean historical PE Ratio of RxSight, Inc. over the last ten years is -4.12. The current -54.03 PE Ratio has changed 130.89% with respect to the historical average. Over the past ten years (40 quarters), RXST's PE Ratio was at its highest in in the December 2020 quarter at 2.90. The PE Ratio was at its lowest in in the June 2024 quarter at -89.83.
Average
-4.12
Median
-5.25
Minimum
-28.58
Maximum
16.03
Discovering the peaks and valleys of RxSight, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 444.37%
Maximum Annual PE Ratio = 16.03
Minimum Annual Increase = -139.45%
Minimum Annual PE Ratio = -28.58
Year | PE Ratio | Change |
---|---|---|
2023 | -28.58 | 444.37% |
2022 | -5.25 | -16.97% |
2021 | -6.32 | -139.45% |
2020 | 16.03 | 357.73% |
The current PE Ratio of RxSight, Inc. (RXST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-13.38
5-year avg
-4.12
10-year avg
-4.12
RxSight, Inc.’s PE Ratio is less than AxoGen, Inc. (-34.41), less than Treace Medical Concepts, Inc. (-5.20), less than Pulmonx Corporation (-4.92), less than Orthofix Medical Inc. (-5.12), less than OrthoPediatrics Corp. (-28.25), less than Sight Sciences, Inc. (-6.06), less than Paragon 28, Inc. (-10.66), less than STRATA Skin Sciences, Inc. (-1.37), less than NeuroPace, Inc. (-6.95), less than Vapotherm, Inc. (-0.26), less than Talis Biomedical Corporation (-0.06), less than Varex Imaging Corporation (13.81), less than Apyx Medical Corporation (-1.59), less than SI-BONE, Inc. (-15.32), less than IRadimed Corporation (30.49), less than CVRx, Inc. (-3.35),
Company | PE Ratio | Market cap |
---|---|---|
-34.41 | $570.66M | |
-5.20 | $331.47M | |
-4.92 | $286.21M | |
-5.12 | $619.96M | |
-28.25 | $742.41M | |
-6.06 | $319.45M | |
-10.66 | $609.86M | |
-1.37 | $13.59M | |
-6.95 | $210.22M | |
-0.26 | $13.55M | |
-0.06 | $2.83M | |
13.81 | $472.39M | |
-1.59 | $45.04M | |
-15.32 | $631.67M | |
30.49 | $568.75M | |
-3.35 | $183.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RxSight, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RxSight, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is RxSight, Inc.'s PE Ratio?
How is the PE Ratio calculated for RxSight, Inc. (RXST)?
What is the highest PE Ratio for RxSight, Inc. (RXST)?
What is the 3-year average PE Ratio for RxSight, Inc. (RXST)?
What is the 5-year average PE Ratio for RxSight, Inc. (RXST)?
How does the current PE Ratio for RxSight, Inc. (RXST) compare to its historical average?